Portfolio company
AbCellera
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AbCellera Biologics
The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.
Zymeworks
The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Abalone Bio
This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.
Solu Therapeutics
This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.
Seranova Bio
This biotechnology company develops autoantibody-based therapeutics and discovery platforms for pharmaceutical partners and clinicians treating autoimmune diseases, cancer and neurodegenerative disorders.
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
